YJGJ Research | Milton Maxwell

YJGJ

Yijia Group Corp.

1.6100

+0.0000+0%

Dec 16, 4:00:00 PM EST

Upcoming Earnings

Report date

≈ -/-

Earnings Call Transcripts

This Quarter (Q1 '26)

No earnings call transcript available yet

Last Quarter (Q4 '25)

No earnings call transcript available

Key Stats

Market Cap

40.27M

P/E (TTM)

53.67

Basic EPS (TTM)

0.03

Dividend Yield

Recent Filings

8-K

Director Zhou resigns

3/18/26Mar 18, 2026

VitaNova Life Sciences lost director Ruiming Zhou, effective March 12, 2026. Her resignation stemmed from no disagreements over operations, policies, or practices. Board shrinks quietly.

10-Q

Q3 FY2026 results

3/16/26Mar 16, 2026

VitaNova's Q3 FY2026 revenue rocketed 130% y/y to $709.6K, driven by dietary supplements ($705K, 99% of total) surging from U.S. and Hong Kong customers, yet gross margin slipped to 44.6% from 61.4% amid higher costs. Operating income fell to $46.7K from $108.9K as G&A jumped to $219.6K (616% y/y, legal fees per MD&A), flipping to a $44K net loss after $91K tax hit—far exceeding $46K operating profit due to income taxes. YTD revenue climbed 75% y/y to $1.24M with $113K operating income, but net loss of $55K reflects tax drag; EPS -$0.01 aligns with 8.34M diluted shares. Cash swelled to $1.17M on $386K operating inflow, no debt. Customer concentration lingers.

8-K

CFO Niu joins board

2/25/26Feb 25, 2026

VitaNova Life Sciences appointed CFO Steve Niu as a director effective February 19, 2026, until the next annual stockholder meeting. Niu, 64, brings 20+ years from Triangle Accounting and expertise in taxation and compliance. No extra pay. He's not independent under Nasdaq standards.

8-K

Name change, split approved

1/27/26Jan 27, 2026

VitaNova Life Sciences completed its name change from Yijia Group Corp. and a 1-for-3 reverse stock split on January 9, 2026, via Nevada filing. FINRA approved both for OTC Pink trading effective January 27, 2026, with ticker shifting to YJGJD temporarily, then VNOV after 20 days. No stockholder action needed. Trading adjusts seamlessly.

8-K

Name change and reverse split effective

1/13/26Jan 13, 2026

Yijia Group Corp. changed its name to VitaNova Life Sciences Corporation and executed a 1-for-3 reverse stock split via Certificate of Amendment filed January 9, 2026, effective that date. FINRA is processing both. Previously increased authorized shares to 210M and designated 3M Series A Preferred shares. New CUSIP: 98585W403; ticker change pending.

About

Yijia Group Corp. provides business consulting services in the United States, Hong Kong, China, and internationally. It operates through two segments; Consulting Service and Healthcare. The company offers consulting advisory services in management business, accounting, and financial services; anti-aging products; and healthcare products and health consultation services. The company was formerly known as Soldino Group Corp. and changed its name to Yijia Group Corp. in November 2018. Yijia Group Corp. was incorporated in 2017 and is based in New York, New York.

CEO

Ms. Qiuping Lu

IPO

4/13/2022

Employees

Sector

Healthcare

Industry

Medical Distribution